Skip to search.
 FTSE 100 Down 1.27%

More On 6MK.DE

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Merck & Co. Inc. (6MK.DE)

-XETRA Ticker: 33Y105/ISIN: US58933Y1055
47.70 Down 1.70(3.45%) 29 Apr 16:01
Prev Close:49.40
Open:48.73
Bid:47.70 x 180000
Ask:47.77 x 20000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:47.70 - 49.36
52wk Range:42.46 - 56.18
Volume:500
Avg Vol (3m):1,096
Market Cap:132.38b
P/E (ttm):30.58
EPS (ttm):1.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infe... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback